TWiV 845: COVID-19 clinical update #94 with Dr. Daniel Griffin

<p>In COVID-19 clinical update #94, Daniel Griffin reviews the FDA EUA for Paxlovid, test to stay in school, immunity after infection, variants and therapeutics, quarantine and isolation guidelines, Molnupiravir in non-hospitalized patients, and convalescent serum in outpatients.</p> <div class="fluid-width-video-wrapper">Hosts: <a href= "http://parasiteswithoutborders.com/">Daniel Griffin</a> and <a href="http://en.wikipedia.org/wiki/Vincent_Racaniello">Vincent Racaniello</a></div> <p>Subscribe (free): <a href= "http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784">iTunes</a>, <a href="https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D">Google Podcasts</a>, <a href= "http://twiv.microbeworld.libsynpro.com/twiv">RSS</a>, <a href="http://eepurl.com/Gcw59">email</a></p> <p>Become a <a href= "https://www.microbe.tv/contribute">patron</a> of TWiV!</p> <h3><strong>Links for this episode</strong></h3> <ul> <li>FDA EUA for Paxlovid (<a href= "https://www.fda.gov/media/155052/download">pdf</a>)</li> <li>Children and COVID-19 (<a href= "https://downloads.aap.org/AAP/PDF/AAP%20and%20CHA%20-%20Children%20and%20COVID-19%20State%20Data%20Report%2012.16%20FINAL.pdf">pdf</a>)</li> <li>Evaluation of <a href= "https://www.cdc.gov/mmwr/volumes/70/wr/mm705152e2.htm?s_cid=mm705152e2_e&ACSTrackingID=USCDC_921-DM72280&ACSTrackingLabel=MMWR%20Early%20Release%20-%20Vol.%2070%2C%20December%2017%2C%202021&deliveryName=USCDC_921-DM72280"> test to stay in school</a>, IL (MMWR)</li> <li>Evaluation of <a href= "https://www.cdc.gov/mmwr/volumes/70/wr/mm705152e1.htm?s_cid=mm705152e1_e&ACSTrackingID=USCDC_921-DM72280&ACSTrackingLabel=MMWR%20Early%20Release%20-%20Vol.%2070%2C%20December%2017%2C%202021&deliveryName=USCDC_921-DM72280"> test to stay in school</a>, LA (MMWR)</li> <li>Update on mRNA vaccine in <a href= "https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provide-update-ongoing-studies-covid-19"> under 5 yo</a> (Pfizer)</li> <li>CDC